A new study by an international team of researchers led by Sweden's Karolinska Institute has for the first time pinpointed a mechanism for the conversion of energy-storing white fat into energy-expending brown fat, a key finding that may lead to the discovery of new diabetes and obesity treatments.
The findings of a new study by Swedish and Chinese researchers into a novel photosensitization-based drug-release system could bring about broad changes in the delivery of cancer therapies, with millions of patients worldwide potentially benefiting from this research.
A new study by an international team of researchers led by Sweden's Karolinska Institute has for the first time pinpointed a mechanism for the conversion of energy-storing white fat into energy-expending brown fat, a key finding that may lead to the discovery of new diabetes and obesity treatments.
The findings of a new study by Swedish and Chinese researchers into a novel photosensitization-based drug-release system could bring about broad changes in the delivery of cancer therapies, with millions of patients worldwide potentially benefitting from this research.
Lowering brain levels of urea and/or ammonia might be a viable new therapeutic target for Huntington's disease (HD), according to the findings of a New Zealand study reported in the Dec. 11, 2017, online edition of Proceedings of the National Academy of Sciences.
Lowering brain levels of urea and/or ammonia might be a viable new therapeutic target for Huntington's disease (HD), according to the findings of a New Zealand study reported in the Dec. 11, 2017, online edition of Proceedings of the National Academy of Sciences.
HONG KONG – Scientists at The Scripps Research Institute (TSRI) in Jupiter, Fla., have developed a new means of identifying promising new drug candidates from microbial natural products, using information stored in the genomes of the bacteria that produce them.
HONG KONG – Scientists at The Scripps Research Institute (TSRI) in Jupiter, Fla., have developed a new means of identifying promising new drug candidates from microbial natural products, using information stored in the genomes of the bacteria that produce them.
